Sources

17 Total Sources

FDA Panel Backs Wider BPC-157 Access in 8-6 Vote, Handing RFK Jr. a Win

Left62%

Center31%

Right8%

The Washington Post10h ago

FDA Committee Recommends Loosening Restrictions on Controversial Peptide, a Victory for RFK Jr.

The New York Times13h ago

F.D.A. Committee Debates Peptide Injections Amid R.F.K. Jr. Influence Concerns

Fox News11h ago

FDA Committee to Review Seven Unapproved Peptides for 503A Bulks List Inclusion

FDA Panel Considers Legalizing Seven Peptides for Consumer Market

FDA Advisory Committee Reviews Seven Peptides for Compounding Pharmacies

The New York Times10h ago

FDA Committee Votes for Wider BPC-157 Peptide Access Amidst HHS Secretary Kennedy's Push

The Associated Press15h ago

FDA Advisers Review Peptide Injections Amid Safety Concerns and Wellness Trend Support

FDA Panel to Consider Easing Peptide Production Restrictions for Pharmacies

FDA Committee to Review Seven Peptides for Compounding Eligibility Amid Public Health Concerns

KSBY News1d ago

FDA Committee to Review Seven Peptide Ingredients for Compounding Use

Al Jazeera English1d ago

FDA Committee to Review Safety and Pharmacy Availability of Seven Popular Peptides

PR Newswire2d ago

Americans Want FDA to End Peptide Roulette, New National Poll Finds

FDA to Discuss Reclassifying Peptides for Legal Pharmacy Compounding

frierlevitt.com2d ago

FDA to Remove 12 Popular Peptides from the Category 2 “Do Not Compound” List - Frier Levitt FDA Peptide Update 2026: Removal from “Do Not Compound” List and What It Means for Pharmacies

FDA is reviewing seven peptides this week, BPC-157, MOTS-c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline

Bloomberg Law2d ago

FDA Panel to Revisit Biden Peptide Ban as It Weighs Looser Rules

10 questions to ask your doctor about peptides | AAMC